WO2006021660A8 - Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation - Google Patents

Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Info

Publication number
WO2006021660A8
WO2006021660A8 PCT/FR2005/001859 FR2005001859W WO2006021660A8 WO 2006021660 A8 WO2006021660 A8 WO 2006021660A8 FR 2005001859 W FR2005001859 W FR 2005001859W WO 2006021660 A8 WO2006021660 A8 WO 2006021660A8
Authority
WO
WIPO (PCT)
Prior art keywords
acid
medicine
fatty acid
preparing
inflammation
Prior art date
Application number
PCT/FR2005/001859
Other languages
English (en)
Other versions
WO2006021660A1 (fr
Inventor
Antoine Piccirilli
Nathalie Piccardi
Philippe Msika
Original Assignee
Expanscience Lab
Antoine Piccirilli
Nathalie Piccardi
Philippe Msika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab, Antoine Piccirilli, Nathalie Piccardi, Philippe Msika filed Critical Expanscience Lab
Priority to US11/572,769 priority Critical patent/US20080045594A1/en
Priority to EP05790724A priority patent/EP1786384A1/fr
Publication of WO2006021660A1 publication Critical patent/WO2006021660A1/fr
Publication of WO2006021660A8 publication Critical patent/WO2006021660A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention a pour objet l'utilisation d'au moins un triène d'acide gras conjugué choisi dans le groupe constitué par l'acide alpha-éléostéarique, l'acide catalpique, l'acide calendique, l'acide jacarique, l'acide licanique et l'acide béta-éléostéarique pour la fabrication d'un médicament destiné au traitement des maladies inflammatoires et/ou des désordres métaboliques consécutifs à une inflammation. Les maladies inflammatoires et/ou des désordres métaboliques consécutifs à une inflammation peuvent être des cancers cutanés, l'érythème solaire, la lucite estivale bénigne, des réactions allergiques et/ou irritatives, des gingivites et des parodontites, des vulvites et des vaginites ou de l'arthrite et de l'arthrose. Le médicament permet également de favoriser la cicatrisation. Ces acides gras conjugués peuvent également être utilisés dans le traitement cosmétique de la cellulite.
PCT/FR2005/001859 2004-07-26 2005-07-20 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation WO2006021660A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/572,769 US20080045594A1 (en) 2004-07-26 2005-07-20 Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation
EP05790724A EP1786384A1 (fr) 2004-07-26 2005-07-20 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408230 2004-07-26
FR0408230A FR2873295B1 (fr) 2004-07-26 2004-07-26 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Publications (2)

Publication Number Publication Date
WO2006021660A1 WO2006021660A1 (fr) 2006-03-02
WO2006021660A8 true WO2006021660A8 (fr) 2006-04-27

Family

ID=34949333

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/001859 WO2006021660A1 (fr) 2004-07-26 2005-07-20 Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Country Status (4)

Country Link
US (1) US20080045594A1 (fr)
EP (1) EP1786384A1 (fr)
FR (1) FR2873295B1 (fr)
WO (1) WO2006021660A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US20100010088A1 (en) * 2007-11-01 2010-01-14 Wake Forest University School Of Medicine Compositions and Methods for Prevention and Treatment of Mammalian Diseases
FR2929515B1 (fr) * 2008-04-08 2014-03-07 Lr Beva Utilisation d'acides gras comprenant un diene conjugue n-5cis, n-7trans ou un triene conjugue n-5cis, n-7trans, n-9cis en tant que medicament
GB0814105D0 (en) * 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
ES2398493T3 (es) 2008-10-24 2013-03-19 Unilever Nv Una composición tópica que comprende extractos de A. Indica y M. Charantia O S. Indicum
GB0902040D0 (en) * 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
FR2949044B1 (fr) * 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
KR100985719B1 (ko) 2009-09-15 2010-10-06 (주)지에프씨 노나무와 무궁화 추출물을 유효성분으로 하는 화장료 조성물
FR2984730A1 (fr) * 2011-12-22 2013-06-28 Diverchim Nouvelles compositions cosmetiques anti-age et depigmentantes
IT201700037319A1 (it) 2017-04-05 2018-10-05 Moss S P A Composizione naturale per uso in ginecologia
WO2019102387A1 (fr) 2017-11-22 2019-05-31 Moss S.P.A. Procédé de production d'une huile d'olive ozonisée

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
FR2762512B1 (fr) * 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
WO2001005416A1 (fr) * 1999-07-15 2001-01-25 Pushpa Khanna Huile extraite de momordica charantia-l., son procede de fabrication et ses utilisations
FR2798667B1 (fr) * 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
AU2001264161A1 (en) * 2000-05-09 2001-11-20 Bioriginal Food And Science Corp. Production of conjugated linoleic and linolenic acids in plants
EP1407679A4 (fr) * 2001-06-21 2005-06-15 Kyowa Hakko Kogyo Kk Procede permettant de produire un extrait vegetal contenant une poudre vegetale
FR2826579B1 (fr) * 2001-06-29 2005-08-05 Pharmascience Lab Composition cosmetique contenant au moins une huile extraite de graines de cucurbitacees, son utilisation cosmetique, therapeutique et alimentaire
DE10158046A1 (de) * 2001-11-27 2003-06-05 Basf Ag Formulierung für den Einsatz in Lebensmitteln, Nahrungsergänzungsmitteln, Futtermitteln, Futterzusatzstoffen, pharmazeutischen und kosmetischen Zubereitungen sowie Verfahren zu deren Herstellung
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
US20040235925A1 (en) * 2002-12-17 2004-11-25 Pharmacia Corporation Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof

Also Published As

Publication number Publication date
WO2006021660A1 (fr) 2006-03-02
FR2873295B1 (fr) 2006-12-01
US20080045594A1 (en) 2008-02-21
FR2873295A1 (fr) 2006-01-27
EP1786384A1 (fr) 2007-05-23

Similar Documents

Publication Publication Date Title
WO2006021660A8 (fr) Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
BR0013897A (pt) Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
EA200700044A1 (ru) Композиция для местного применения
ITRM980239A0 (it) Assieme protesico da impiegarsi nelle terapie chirurgiche del prolasso urogenitale
MX2008001503A (es) Composicion cosmetica o dermatologica para la prevencion o el tratamiento de piel sensible o seca.
EP2298863A3 (fr) Cellules souches mésenchymateuses et utilisations associées
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
ATE412417T1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
SE0302923D0 (sv) Boswellin compositions enhanced with 3-beta-acetyl-11-keto- beta-boswellic acid (AKBA), industrial manufacture and their uses
CY1108633T1 (el) Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
PA8447801A1 (es) Derivados del acido hexanoico
WO2007047486A3 (fr) Esters hydroxy-oligocarboxyliques: effets sur un nerf et utilisation sur des organes ou des sites cutanes et mucocutanes
ZA200204157B (en) Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions.
DK1341517T3 (da) Et hudcremepræparat
AR036400A1 (es) Regulacion combinada de la produccion de celulas nerviosas.
WO2008000974A3 (fr) Composition cosmetique a base d'acide gras polyinsatures et ses utilisations
BRPI0716108B8 (pt) composição, uso de uma composição, e, método para fabricação de uma composição
ZA957507B (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
NZ334593A (en) Use of zinc salts of conjugated linoleic acids to treat skin disorders particularly eczema, psoriasis and dermatitis and their use in the treatment of skin cancer
WO2008046541A3 (fr) Composition de gel filmogène pour soigner la peau ou une blessure
WO2004034958A3 (fr) Utilisation d'un amide ou d'un ester de sucre et d'acide gras dans le traitement et/ou la prevention de la peau seche
WO2008078050A3 (fr) Utilisation d'au moins un acide gras mono-insature pour le traitement des peaux, muqueuses ou semi-muqueuses et cuirs chevelus fragiles
CO4970834A1 (es) Composiciones que contienen combinaciones de poliesteres de acidos grasos de poliol solidos y un aceite solido

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11572769

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005790724

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005790724

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11572769

Country of ref document: US